News & Press Releases
Filter by:
Mintz Advises on Wave Life Sciences $402.5 Million Public Offering
December 12, 2025
Mintz advised Wave Life Sciences in its $402.5 million public offering.
Mintz advised Cultivo, a leading platform for developing and operating natural assets at scale, on its acquisition of leading carbon grasslands project developer Kateri.
Mintz Advises SILAC on Acquisition by Hildene Capital Management
December 10, 2025
Mintz advised SILAC, Inc., the parent company of SILAC Insurance Company (“SILAC”), a leading provider of fixed and fixed indexed annuity products in the US, on its definitive agreement to be acquired by Hildene Capital Management, an $18+ billion credit-focused alternative asset manager, for approximately $550 million in cash.
Mintz Advises on Capricor Therapeutics’ $150 Million Public Offering
December 10, 2025
Mintz advised the underwriters in connection with Capricor Therapeutics’ $150 million public offering.
FCA Bar Eager to Scrutinize 11th Circ. Qui Tam Debate
December 9, 2025
Comments from White Collar Defense and Government Investigations Practice Co-chair Eóin Beirne and Litigation Associate Grady Campion were featured in a Law360 Healthcare Authority article previewing oral arguments in an Eleventh Circuit case challenging the constitutionality of the False Claims Act’s whistleblower provisions. This is a closely watched case that could ultimately head to the Supreme Court.
Mintz Advises Relation Therapeutics on Additional Funding Round, Including Strategic Investment from Novartis
December 09, 2025
Mintz advised Relation Therapeutics, a technology-enabled biopharmaceutical company, on its strategic collaboration with Novartis, leading on the negotiation of an equity investment from Novartis.
